Post by Axxam

The French Crédit d'Impôt Recherche (CIR) accreditation remains in place for Axxam. As an approved R&D service provider under the French CIR program, Axxam can continue supporting eligible French companies with outsourced research activities that may qualify for CIR tax incentives. For biotech, pharma, and life science organizations, this represents an additional opportunity to maximize the value of their R&D investments while accessing Axxam's integrated drug discovery expertise. Contact our team to learn more about how we can support your next research project. #CIR #CreditImpotRecherche #DrugDiscovery #Biotech #Pharma #ResearchAndDevelopment